Trials / Not Yet Recruiting
Not Yet RecruitingNCT07090876
Hemodynamic Effects of a Standardized Grape Seed Extract Supplementation
Hemodynamic Effects of a Standardized Grape Seed Extract Supplementation: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Indena S.p.A · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate whether a standardized grape seed extract, compared to placebo, can significantly influence systolic blood pressure (SBP) in individuals with high-normal blood pressure (BP) who are adhering to a low-sodium Mediterranean diet. Additionally, the effects of the grape seed extract on diastolic blood pressure (DBP), other hemodynamic parameters, and the Perceived Stress Score will be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Standardized Grape Seed Extract | Grape seed dry extract standardized to provide: ≥95.0% of proanthocyanidins by spectrophotometry, ≥5.0% ≤15.0% of catechin and epicatechin by High-Performance Liquid Chromatography (HPLC) |
| OTHER | Placebo | Placebo |
Timeline
- Start date
- 2025-12-01
- Primary completion
- 2027-01-30
- Completion
- 2027-01-30
- First posted
- 2025-07-29
- Last updated
- 2025-11-20
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT07090876. Inclusion in this directory is not an endorsement.